Xspray Pharma’s Rights Offering

Vinge advised Xspray Pharma on the deal. Xspray Pharma AB (publ) completed a rights issue of shares whereby Xspray receives issue proceeds of approximately SEK 135...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Stendörren Fastigheter’s Share Offering

Vinge advised Stendörren Fastigheter on the deal. Stendörren Fastigheter AB (publ) secured a directed share issuance through which the company raises proceeds of approximately SEK 505...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Pandox’s Shares Offering

Vinge advised Pandox on the deal. Pandox Aktiebolag (publ) completed a directed share issuance through which the company raises proceeds of approximately SEK 2 billion before...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Borgo’s Financing Round

Vinge advised Borgo on the deal. Borgo completed a capital raising of SEK 357 million. The capital is invested by the existing owners and Lan &...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Hansa Biopharma’s Shares Offering

Vinge advised Hansa Biopharma AB on the deal. Hansa Biopharma AB (publ) finalized a directed share issue through which the company raises proceeds of SEK 372 million...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Tobii AB’s Rights Offering

Vinge advised Tobii AB on the offering. Tobii AB (publ) finalized its rights issuance of ordinary shares which will provide Tobii with issue proceeds of approximately...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here